Defining Peyronie's disease
Peyronie's disease has been termed a fibromatosis. However, the exact definition of a fibromatosis is a condition characterized by the development of multiple fibrous tumors. Fibromatoses have a range of biologic behaviors from completely benign (osteosclerosis, Dupuytren's contracture) to aggressive with malignant potential (ovarian thecoma, desmoid tumor). Other than the coexistence in some men with Dupuytren's contracture, the presence of other fibrous tumors in men with Peyronie's disease has not been identified. Peyronie's disease has not been recognized as a condition with the potential for malignant transformation, although some suggest that there may be an association between it and the development of epitheloid sarcoma of the tunica. 1 However, it is interesting to note that at the time of plaque incision and grafting surgery, plaque tissue is often adherent to the corporal smooth muscle. Pathologically, extension of the fibrosis into the smooth muscle fibers may be seen, suggesting that Peyronie's disease may be locally aggressive. 2 On the other hand, fibrotic disorders are conditions characterized by fibrosis in a tissue, organ or organs. These conditions are generally localized in nature and nonaggressive in their biology. Examples of such conditions include idiopathic hepatic fibrosis and atherosclerosis. It is therefore more likely that Peyronie's disease represents a fibrotic disorder rather than a true fibromatosis.
From a clinical perspective how do we define Peyronie's disease? Clearly, the symptoms and signs are well appreciated. The pathology has been reasonably well elucidated, yet the natural history has been poorly studied. Therefore, we probably do not completely understand all of the characteristics of the condition. Might Peyronie's disease be a heterogeneous disorder? Certainly, there is a variation in the biology of the condition, with some patients experiencing resolution of their penile deformity, while others may experience profound progression over a short period of time. Are these factors a function of the variability in fibrotic process or variability in the body's response to this process? This question currently remains unanswered. The current figures from the prevalence are higher than those cited a decade ago. Is this a function of clinicians looking more closely for the condition or patients being more aware of it?
Models for the study of Peyronie's disease
The generation of a reliable, reproducible model for Peyronie's disease is a vital requirement for the advancement of our understanding of this disease process and is also essential for the evaluation and development of novel therapeutic strategies. Currently, there are two types of models being investigated. Cell culture models have been used extensively in other areas of research and were first described in Peyronie's disease by Somers et al 3 in the late 1980s. The purpose of an in vitro model is to provide a model that is derived from the constituent cells of the tissue being studied. The advantages of such a model include the ability to characterize the biology of the condition and the ability to manipulate the cells using a variety of agents, which may allow the development of new therapies. The major disadvantage is that such models may fail to represent the in vivo condition. The study of Peyronie's disease plaque-derived fibroblasts, for example, does not account for the complex in vivo environment in which the cells normally exist and function. In Peyronie's disease, cell culture models have been used to study fibroblast growth characteristics, cytogenetic changes, cell cycle regulator function and cytokine expression. [4] [5] [6] [7] Another ex vivo model is the use of plaque tissue for experimental investigation. This model is useful for the study of the presence of proteins and mRNA within this tissue. It has also been recently utilized for microarray analysis, a contemporary strategy commonly used for hypothesis generation in basic science research. 8 The second model under development and exploration is an animal model. The purpose of developing an animal model is to develop a model that precisely mimics the in vivo process. Through such a model, expansion of the understanding of the pathophysiology of Peyronie's disease may be possible. The potential advantages of such a model include the ability to assess therapeutic interventions prior to human exposure. For an animal model to be valid, however, it must adequately represent the condition being studied. In Peyronie's disease, the most widely studied model has been developed by the UCSF group and involves the injection of cytomodulin, a synthetic heptapeptide with TGF-b like activity, into the tunica albuginea of the rat. 9 This technique has been shown to replicate the pathology of Peyronie's disease that is profound fibrosis. The use of this specific agent arose from the finding that the TFG-b was overexpressed in Peyronie's disease plaque tissue compared to control tunica. 10 Much experimentation is being performed on the penises of rats injected with cytomodulin and much hypothesis generation is also being conducted based on this model. The potential deficiency of such an approach is that it may fail to take into account the upstream factors that lead to the overexpression of TFG-b. Clearly, this model is representative of penile fibrosis, but may not be an ideal model for the study of Peyronie's disease. More recently, the UCLA group has substituted fibrin for cytomodulin with identical pathologic changes in the tunica in response to injection. The potential limitations of this model are the same as those for the original UCSF model.
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Proposed pathogenetic mechanisms: evidence-based analysis
The precise etiology or etiologies of Peyronie's disease remain uncertain. Historically, a number of factors have been cited as potential contributors to the pathogenesis of a Peyronie's disease plaque ( Figure 1 ). These include, trauma to the penis in the erect or semierect state, overproduction of collagen and alterations in the type of collagen deposited in the tunica, overproduction of cytokines that induce fibrosis, alterations in T-cell-mediated immunity and HLA associations, failure to degrade and clear fibrin from the tunica albuginea, free radicals and chromosomal instability.
Trauma
The concept introduced by Horton and Devine that trauma to the penis leads to Peyronie's disease continues to be accepted two decades after its introduction. [12] [13] [14] Trauma is believed to be the primary inciting event in the cascade of events that leads to Peyronie's disease plaque development. 15 The torqueing stresses that occur during penetrative sexual relations are believed to result in delamination of the tunical fibers, resulting in microhemorrhages, acute then chronic inflammation and eventually scar formation. Interestingly, however, the minority of patients give a history of a distinct traumatic episode. In a questionnaire-based study, patients with Peyronie's disease and erectile dysfunction (ED) had an increased likelihood of having sustained penile trauma than patients without either Peyronie's disease or ED. There was no difference in trauma reporting between patients with Peyronie's disease when compared to men with ED. 16 The trauma theory is attractive; however, there is a dearth of evidence-based analyses to evaluate its role in the genesis of Peyronie's disease plaque. Despite this, it can be easily appreciated that the penis may be torqued during sexual intercourse and the location of the majority of plaques in dorsal and ventral locations is consistent with the ventro-dorsal stresses that are inflicted on the penis during sexual intercourse. The question remains as to why is it that so few men develop this condition if the majority have sexual relations in a similar fashion. It is likely that while trauma is an important contributor, that alone is unlikely to produce Peyronie's disease and needs to be combined with other biologic factors to result in the profound fibrotic reaction that leads to plaque development.
Failure of fibrin degradation
The concept that fibrin accumulation leads to profound tunical scarring was put forth by Somers and Dawson. 17 This was based upon a pathological examination of plaque tissue from men with Peyronie's disease. The plaque tissue was examined for collagen, elastin and fibrin content. The findings in Peyronie's disease plaque tissue were compared to the findings in control tunica and Dupuytren's contracture tissue. Immunohistochemistry demonstrated that fibrin was present in 95% of the plaque tissue and was not seen in the control tissues. These findings were confirmed using immunoblotting techniques for fibrin. 17 These findings were also documented, although not as consistently, in Dupuytren's contracture tissue. Recently, as mentioned above, because of these pathological findings, the UCLA group has utilized fibrin injection into the rat tunica to develop a novel animal model. While the Somers study demonstrates the presence of fibrin in Peyronie's disease plaque tissue, it tells us little about its role nor of the events that lead to fibrin deposition and more importantly the reason for the failure of fibrin degradation.
Collagen alterations
Pathologically, collagen deposition is increased in the tunica albuginea. Furthermore, there is disorganization of the native collagen bundles and a reduction in elastin fiber presence with disorganization. 18 Using immunohistochemistry, Somers and Dawson 17 demonstrated that plaque tissue had aberrantly stained collagen and disruption of elastin fibers in excess of 90% of specimens studied. It has also been shown that there is a shift in the type of collagen deposited, from the predominant type I to type III, [19] [20] [21] although these findings have not been reported in a consistent fashion. Regardless of the upstream events involved in the pathogenesis of Peyronie's disease, it is clear that the development of fibrosis follows a pathway similar to wound healing, except that the normal termination signals are altered resulting in excessive deposition of extracellular matrix (ECM), which is predominantly collagen, and destruction of normal tissue architecture and function. Thus, dysregulated wound healing process serves as the conventional paradigm for the study of this condition. Tissue injury initiates a complex cascade which involves the (1) activation of monocytes, macrophages and platelets, (2) release of cytokines and growth factors (3) fibroblast recruitment and proliferation and (4) increased synthesis and decreased degradation of ECM. While in normal wound healing an, as of yet, unidentified mechanism terminates ECM production when healing is complete, in Peyronie's disease the wellorchestrated control mechanisms of normal wound healing are lost which results in the characteristic fibrosis.
Genetic predisposition
Most authorities affirm that the majority of men suffering from Peyronie's disease are Caucasian. Thus, it is easy to see why interest exists in the concept that perhaps there is a familial or genetic predisposition to this condition. Some reports have suggested either familial clustering or autosomal dominant transmission of this condition. 22 In 1982, Chilton et al conducted a retrospective review of 408 patients and found a familial incidence in 1.9% of the patients. In this study, there was also a 15.3% incidence of Dupuytren's contracture in Peyronie's disease patients. The authors thus state that there was a 17% incidence of genetic causes of Peyronie's disease. This study has not been replicated in the modern era, therefore, it is uncertain what role genetics plays in this condition.
Autoimmune factors
Autoimmune response secondary to trauma has been documented in a number of other organs systems, including the testis (generation of antisperm antibodies in response to testicular trauma or surgery) and the eye (sympathetic opthalmitis in response to penetrating trauma to the contralateral eye). 23 Thus, it can be appreciated that trauma to the tunica albuginea might set up an autoimmune reaction that leads to further fibrosis and destruction of the tunica. There are a number of reports assessing HLA linkage. [24] [25] [26] [27] [28] [29] Nachsteim and Rearden 24 analyzed serum of 31 men with Peyronie's disease for class II HLA antigens and compared the findings to 19 aged-matched urologic patients as well as 75 organ donor cadavers believed to be representative of the general population. Using PCR technology, the frequency of HLA-DQ5 was greater in Peyronie's disease patients compared to controls (61 vs 19%), suggesting a role for an autoimmune component in this disorder. Ralph et al 28 performed tissue-typing in 51 patients with documented Peyronie's disease and found a significant association between Peyronie's disease and HLA-B27. However, no significant association was found with other HLA-B group antigens or HLA-Cw7, HLA-DR3, HLA-DQ2. These latter findings confirmed earlier work by Leffel et al. 30 It is thus conceivable that penile trauma in a patient with a predisposing HLA type may be required for the development of a tunical plaque. Could the ethnic difference in the predilection for Peyronie's disease be accounted for by such a simple explanation? It is likely that large cohorts of Peyronie's disease patients of multiethic origin would need to undergo HLA typing to answer this question. Schiavino 31 demonstrated that in patients with Peyronie's disease, 76% had at least one abnormal immunological test, 48% had an abnormality in Tcell-mediated immunity and 38% had markers of autoimmune disease. 25, 32 Stewart et al 32, 33 showed an increase in levels of antielastin serum antibodies in men with Peyronie's disease. Ralph et al 29 studied the sera of 100 men with Peyronie's disease for circulating antibodies. Circulating anti-penis antibodies were not demonstrated in serum. Plaque tissue was also assessed and demonstrated the deposition of IgM antibodies as well as T lymphocytes within the subtunical space. Thus, it appears that there are some features of autoimmunity present in a consistent fashion, in particular, it appears that cell-mediated immunity is altered in this condition. It is probable that this does not represent an intrinsic deficiency in the immune system of Peyronie's disease patients rather that it is a local phenomenon confined to the tunica albuginea.
Infection
There has been minimal exploration of the role of pathogens in this condition. Ralph et al 34 analyzed fecal, urine and urethral samples for the presence of bacteria including Yersinia, Salmonella, Shigella, Campylobacter, Gonococcus and Chlamydia. Serum titers were also assessed for antibacterial antibodies. All specimen cultures were negative and Peyronie's disease patients failed to show any elevation of serum titers for anti-Klebsiella, anti-Proteus or antiEscherichia coli antibodies. Thus, up until this point in time no data have been generated that support the role for an infectious agent.
Arterial disease
Pathological findings demonstrating perivascular cuffing with round cells has led some to suggest the underlying arterial disease or vasculitis as a component of the Peyronie's disease process.
2, 35 The presence of microhemorrhages has also been documented within the tunica and it has been postulated in other disease states that exposure of the vascular media may instigate a reaction that is fibrogenic in nature. Parums et al 36 analyzed the serum of patients with periaortitis for anti-ceroid antibodies and demonstrated elevated levels. It is likely that arterial or periarterial changes are the result of the Peyronie's disease process and do not represent an underlying mechanism.
Free radicals
Free radicals include reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI). The generation of free radicals has been postulated in Peyronie's disease tissue. 37 ROS are free radicals derived from oxygen and are highly oxidant in nature. ROS include superoxide anion (O À ), hydrogen peroxide (H 2 O 2 ) and hydroxyl anion (OH À ). RNI include nitric oxide (NO) and peroxynitrite (OONO À ). The presence of these free radicals is entitled a state of 'oxidative stress'. The current understanding of the role of oxidative stress in Peyronie's disease is incomplete. There exists some data to support the use of antioxidants (vitamin E, superoxide dismutase) in the treatment of Peyronie's disease; however, as with much of the data regarding medical therapy for Peyronie's disease, the results are mixed. 38, 39 Much of the discussion regarding free radicals in Peyronie's disease is based upon the documented cellular response and the finding of round cells in Peyronie's disease plaque tissue on histologic sections. There are data to support the presence of peroxynitrite overexpression in cavernosal tissue of men with Peyronie's disease as well as peroxynitrite overproduction in the rat model of Peyronie's disease. However, there do not exist data to date, to demonstrate that free radical play a direct role in Peyronie's disease plaque tissue itself. Sikka and Hellstrom 40 have suggested that ROS and RNI function through the intermediary NF-kB by upregulating genes involved fibrogenesis as well as the gene for nitric oxide synthase (NOS). Currently, the exact role of free radicals in Peyronie's disease remains ill defined.
Cytogenetic alterations
Since previous experiments by others in Peyronie's disease and the associated Dupuytren's contracture have indicated macroscopic changes in specific chromosomes, exploration of cytogenetic alterations has been conducted in Peyronie's disease cultured fibroblasts. Cytogenetic studies of fibroblasts grown from the related fibromatosis, Dupuytren's contracture, have also revealed chromosomal instability in the majority of fibroblasts from the fibrotic palmar fascia, specifically, an increase in the number of copies of chromosomes 7 and 8, as well as deletions of the Y chromosomes. A number of studies have demonstrated that the disease process occurring in Dupuytren's contracture was found to involve marked chromosome instability, in particular, trisomy of chromosomes 7 and 8. 41 , 42 Somers et al examined cell cultures derived from Peyronie's disease plaque tissue, adjacent tunica, dermis and lymphocytes in patients with Peyronie's disease using karyotyping, and compared the results to cell cultures established from the tunica albuginea of control patients. Chromosomal abnormalities were detected in seven of 12 Peyronie's disease patients (58%). Thus, the similarity in cytogenetic findings between Peyronie's diease and Dupuytren's contracture suggests the potential for a common pathway for fibrosis, which occurs in both of these conditions. Regardless of the inciting event, the pathological fibrosis that ensues is the result of the normal wound healing process gone awry.
We have undertaken studies of numerical changes in specific chromosomes using flourescent in-situ hybridization (FISH). 7, 43 For these studies, we used probes to chromosomes 7, 8, 17, 18, X and Y. These specific chromosomes were selected based on chromosomes that were aneusomic in Dupuytren's contracture. 41, 42 On FISH microscopy, we have demonstrated consistent aneusomies in Peyronie's disease plaque-derived fibroblasts compared to normal chromosomal complement in control fibroblasts. One of the other interesting findings is that these chromosomal aberrations are present in plaque-derived fibroblasts at very early passages, thus it is probable that these alterations are present at the commencement of cell culture and do not represent culture artifact. The presence of aneusomies in early passage plaque-derived cells, combined with the absence of any cytogenetic instability in either foreskin or normal tunica-derived fibroblasts, suggests that chromosomal instability in Peyronie's disease plaque-derived fibroblasts is not the result of culture artifact and, is therefore, likely to be of significance. We have furthermore demonstrated in men with Peyronie's disease that fibroblasts derived from tunica extracted from an area remote from the actual plaque also demonstrate cytogenetic changes, suggesting that Peyronie's disease may be a field defect of the tunica albuginea. 43 This would suggest that the tunica of men with Peyronie's disease itself is predisposed to the development of this condition. The cytogenetic changes however are at the cellular level and are not systemic alterations. It is again likely that these alterations are the result of upstream events that result in chromosomal instability.
Other workers have explored cytogenetic changes in Peyronie's disease fibroblasts. Recently, Yamanaka et al 44 assessed DNA isolated from Peyronie's disease plaque tissue for loss of heterozygosity (LOH) and microsatellite alterations (MSI). Using polymerase chain reaction (PCR) technology, chromosomes 3, 8 and 9 were selected and 20 different polymorphic markers were used to assess for MSI and LOH. In all, 40% of the patients demonstrated MSI and/or LOH on at least one locus. These data confirm that cytogenetic instability is prevalent in Peyronie's disease tissue and that it is probably more widespread throughout the plaque-derived fibroblast genome than previously demonstrated.
Cytokine overexpression
Since the early observations of Alexis Carrel, who noted that substances within embryonic juices affected cell proliferation, cytokines have been identified as ubiquitous. Cytokines are subdivided into proinflammatory (such as, the interleukins), antifibrotic (such as, the interferons) and profibrotic. 45, 46 The profibrotic or fibrogenic cytokines include, TNF-a, TGF-b, FGF and PDGF families. The latter function by increasing collagen production by fibroblasts as well as increasing fibroblast proliferation rates. A number of workers have demonstrated the overexpression of cytokines in Peyronie's disease. 5, 10 Lue and co-workers have evaluated the role of TGF-b in Peyronie's disease. 10 The protein expression of growth factors We have analyzed supernatants from cell culture for levels of basic fibroblast growth factor (bFGF) using an enzyme-linked immunoadsorbent assay (ELISA). 5 ELISA analysis demonstrated that plaque-derived fibroblasts produced four-fold more bFGF than foreskin-derived fibroblasts. As basic FGF is a fibrogenic cytokine inducing the production of extracellular matrix by fibroblasts as well as being mitogenic for fibroblasts, the demonstration of its overexpression by Peyronie's disease plaquederived fibroblasts suggests a role for this cytokine in the pathogenesis of Peyronie's disease.
More recently, the UCSF group have demonstrated overexpression of monocyte chemoattractant protein (MCP-1) in plaque and normal tunica tissue from men with Peyronie's disease compared to control cells. 47 Furthermore, they have shown that MCP-1 is upregulated when cells are treated with TFG-b. Thus, there is robust evidence to support a role for a number of fibrogenic cytokines in the pathogenesis of Peyronie's disease. Manipulation of fibrogenic cytokine production has been explored experimentally in other conditions and represents a potential strategy in Peyronie's disease. 48 
Cell cycle dysregulation
Besides increased deposition of collagen, Peyronie's disease is characterized by cellular overproliferation. p53 is intrinsically involved in cell cycle regulation, apoptosis and DNA damage repair pathways. Aberrant p53 function leading to cell proliferation and immortalization has been implicated in benign and malignant proliferative disorders. 49 Absence, alteration or loss of function of this protein may allow damaged cells, normally halted from passage through the cell cycle, to pass and proliferate, resulting in unregulated cell replication. Using immunoflourescence, we have demonstrated cellular p53 protein expression in Peyronie's disease plaque-derived fibroblasts but not in control fibroblasts. 6 The difference in p53 expression between each individual plaque-derived cell culture and foreskin cells was highly statistically significant. The data clearly demonstrate the presence of p53 in plaque fibroblasts, while foreskin fibroblasts demonstrate only a background level of immunoflourescence indicating no detectable p53. More recently, immunoblotting has confirmed detectable levels of p53 in the Peyronie's disease plaque-derived fibroblasts. 50 On flow cytometric analysis, the neonatal foreskin fibroblasts' response to irradiation was characterized by an expected increase in the percent of both G 1 and G 2 /M populations, with a concomitant decrease in percent S-phase cells, demonstrating the presence of functioning cell cycle checkpoints. In contrast to these findings, plaque fibroblasts showed little change in cell cycle compartments following 5 Gy gamma irradiation indicating that the p53 pathway is nonfunctional in plaque fibroblasts and thus, there is a lack of functioning cell cycle checkpoints in these cells. 6 These data represent the first indication that there is an abnormality in the p53 pathway in plaque-derived fibroblasts. This supports previous findings from analyses of p53 function in other fibromatoses. 51, 52 The implications of p53 abnormalities in Peyronie's disease are unknown but potentially far reaching.
In a confirmatory study high passage Peyronie's disease plaque-derived fibroblasts were injected into mice with severe combined immunodeficiency (SCID) and demonstrated tumorigenicity. 53 This finding illustrates that fibroblasts derived from Peyronie's disease plaque are biologically transformed, which in turn suggests that these cells have an altered genome, supporting a potential role for upregulation of proto-oncogene(s), downregulation of suppressor gene(s) or inclusion of exogenous DNA into the cellular genome. Biologically transformed fibroblasts have higher proliferation rates, produce more collagen and demonstrate chromosomal instability, all of which have been demonstrated in our cell culture model of Peyronie's disease.
NOS and Peyronie's disease
Recently, a great deal of interest has arisen in the role of NO and NOS in the pathophysiology of Peyronie's disease. Both NO and NOS are well known to andrologists because of the role they play in erectile function. NOS includes three varieties, neuronal (NOS I), endothelial (NOS III) and inducible (NOS II) or iNOS. 54 The latter is produced by smooth muscle cells, macrophages among other cell types. The production of iNOS is stimulated by cytokines (IL-1, TNF-a), interferon, endotoxin and NF-kB. 55 At supraphysiologic levels, NO resulting from iNOS upregulation starts to play a role as an oxidant generator. Peroxynitrite is a potent free radical and is a poor vasorelaxant and can be generated from excess NO. The role of iNOS in wound healing is confusing. Under certain circumstances it promotes wound healing, under others it may be fibrogenic and destructive. Recent data suggest that mice deficient in iNOS experienced delayed wound healing. On the other hand, iNOS may play a role in fibrogenesis, for example, inhibition of iNOS decreases fibrosis in an animal model of collagen-induced arthritis. Bivalacqua et al 55 have demonstrated increased levels of iNOS protein and decreased levels of eNOS protein in the cavernosal tissue of men with Peyronie's disease.
Vernet et al 56 have explored the impact of NO on fibroblast differentiation in the rat model of Peyronie's disease. Myofibroblasts are present in Peyronie's disease plaque and represent a distinct population of cells in cells cultured from Peyronie's disease plaque tissue. These workers found that the myofibroblast population was increased in human Peyronie's disease plaque tissue as well as in rat tunica after TFG-b injection when compared to control tunica. Furthermore, chemical inhibition of iNOS resulted in an increase in myofibroblast number, suggesting that iNOS may play some role in limiting the myofibroblast population in an effort to reduce tunical scarring and contraction. Thus, while defining the contribution of iNOS and NO in the genesis of Peyronie's disease is in its embryonic stages and much work remains to be done preliminary data indicate that there is probably a role played by these factors in the pathophysiology of Peyronie's disease.
Microarray analysis
The UCLA group has used this contemporary technology to assess for genes that are upregulated in plaque tissue extracted from men with Peyronie's disease. 8 This approach has been successfully applied to other disease entities including prostate disease, renal cell carcinoma, colon cancer, aging and multiple sclerosis. mRNA levels were compared between plaque and normal tunica tissue using two distinct gene chips (Clontech and Affymetrix). This group found several genes that were upregulated and a small number which were down regulated. In summary, the finding indicated that genes involved in matrix production (procollagenase IV) and cell proliferation (c-myc, protomysoisn-a) were upregulated and those involved in matrix degradation (elastase IIB) were downregulated. The utilization of gene chips has allowed the development of 'disease-related profiles' which will further our understanding of the biology of this condition and may permit the development of novel therapeutics.
Expanding the paradigm
We have adopted a broader view of Peyronie's disease and its pathophysiology and have analyzed the literature as it pertains to other fibrotic disorders such as ovarian thecoma, desmoid tumor, proliferative scar and atherosclerosis in an attempt to unearth unexplored avenues of potential research. The above conditions all share some features with Peyronie's disease (Table 1) , specifically, cytokine overexpression, collagen alterations, cytogenetic aberrations, cell cycle dysregulation, autoimmune alterations and tumorigenicity in immunocompromised animal models.
We have become interested in atherosclerosis because of its prevalence and the fact that it shares some features with Peyronie's disease, specifically the fact that it is characterized by the formation of a fibrotic plaque, which results from cellular overproliferation. Recent evidence supports a role for infectious agents in the development of atherosclerosis as well as the development of arterial restenosis following coronary artery angioplasty. [57] [58] [59] [60] [61] In the latter condition, endoluminal trauma, such as that which occurs during balloon angioplasty, is believed to reactivate the implicated pathogens. This reactivation leads to hyperplastic growth of the fibroblasts within the arterial wall and subsequent fibrosis and arterial occlusion. The altered cell growth and the association with trauma make pathogen-associated arterial disease a potential model for the study of Peyronie's disease. For years, seroepidemiologic evidence has supported a link between cytomegalovirus (CMV) and atherosclerosis. Elevated CMV antibody titers are more common in patients undergoing surgery for atherosclerotic disease when compared to matched control patients. CMV has also been implicated in the development of post-angioplasty restenosis, carotid artery intimal thickening and accelerated atherosclerosis in cardiac transplant patients. It has proven difficult to culture CMV (and herpesviridae in general) from atheromata. However, failure to culture virus particles does not preclude their involvement in the genesis of atherosclerosis. Indeed, there is excellent documentation supporting a role for the herpesviridae in triggering diseases without persisting in an infectious form in the affected tissue. This has been termed the 'hit-andrun' mechanism. While CMV infiltrates endothelial cells and smooth muscle cells, it is well recognized that CMV has a particularly high affinity for fibroblasts. Preliminary work in our laboratory has identified CMV DNA in some of our Peyronie's disease plaque-derived fibroblasts using nested PCR techniques. Confirmation of these early results in all of our cell cultures will be required to confirm this as a possible contributor to the pathogenesis of the condition. If confirmed that CMV is present in Peyronie's disease fibroblasts, further work will be required to define whether it represents an innocent bystander or if it plays a significant role in the genesis of plaque.
More recent work has also implicated the pathogen Chlamydia pneumoniae in the pathogenesis of atherosclerosis. 62 While the evidence linking C. pneumoniae to atherogenesis is not as strong as that implicating CMV, there is evidence using a variety of techniques, including immunocytochemistry. The association of CMV and C. pneumoniae with atherosclerotic arterial disease may represent a model for Peyronie's disease, because trauma to the semierect penis is believed to be the inciting event in the pathogenesis of Peyronie's disease and CMV in particular is reactivated by trauma. Figure 2 outlines a novel paradigm for the pathophysiology of Peyronie's disease. Penile trauma in a susceptible individual leads to activation of endogenous factors within the tunica albuginea that initiates a series of events that may include loss of suppressor genes or upregulation of promoter genes that eventuate in aberration in cell cycle regulator function. These changes result in biologic transformation of the fibroblasts within the tunica albuginea and leads to further alterations including NOS changes, cytogenetic instability, free radical generation and fibrogenic cytokine overproduction. The conglomeration of these factors finally leads to unregulated ECM deposition that develops into a plaque. Is it possible that trauma to tunica albuginea that is infiltrated with a dormant pathogen in a genetically predisposed individual (HLA-associated) is the combination of factors that leads to plaque development.
Summary
We are at a point in history when the quality of the basic scientific research in Peyronie's disease is at the highest level it has ever been. It is probable that the etiology of this condition is multifactorial; that the inciting event is repetitive minor trauma to the erect or semierect penis in a man who is genetically predisposed and whose tunica albuginea is primed in some fashion to respond with a proliferative fibrotic reaction. It is likely that with the various investigators approaching this condition in their own respective fashions that our understanding of the condition will grow and that we will in the nottoo-distant future have a clearer insight into the exact pathophysiology. To end this treatise, the words of Tom Lue MD I believe ring true 'y urologists are left with no research funding, no institutional support and no patient advocates in helping the fight against the disease. Nevertheless, armed with our scientific curiosity, innovative minds and sincerity to serve our patients y we will eventually prevail.' 
